AHCO
AdaptHealth Corp.
NASDAQ · Healthcare · Medical - Devices · US
$7.28
+16.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.2B | 3.2B | 3.3B | 3.2B | 3.0B |
| Cost of Revenue | 2.0B | 2.7B | 2.6B | 2.5B | 2.6B |
| Gross Profit | 367.8M | 568.6M | 681.1M | 681.8M | 417.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 388.6M | 382.3M | 359.2M | 190.1M | 162.1M |
| General & Admin Expense | 388.6M | 382.3M | 359.2M | 190.1M | 162.1M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 144.5M | — | 58.1M | 1.1B | 64.9M |
| Total Operating Expenses | 533.1M | 382.3M | 417.4M | 1.3B | 227.0M |
| Cost and Expenses | 3.4B | 3.1B | 3.0B | 3.8B | 2.8B |
| Operating Income (EBIT) | (232.5M) | 186.3M | 263.7M | (598.4M) | 190.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 104.8M | 105.8M | 126.7M | 130.3M | 109.4M |
| Net Interest Income | (76.2M) | (105.8M) | (126.7M) | (130.3M) | (109.4M) |
| Other Non-Op Income/Expense | (235.5M) | (201.4M) | (127.7M) | (125.4M) | (92.5M) |
| Non-Operating Income (excl Interest) | 128.0M | 95.7M | 1.0M | (6.7M) | (16.9M) |
| EBT (Pre-Tax Income) | (468.0M) | (15.2M) | 136.0M | (723.8M) | 97.9M |
| Income Tax Expense | (40.4M) | 50.9M | 41.2M | (49.0M) | 24.8M |
| Bottom Line | |||||
| Net Income | (406.7M) | (70.8M) | 90.4M | (678.9M) | 69.3M |
| Earnings from Cont. Ops | (414.5M) | (66.0M) | 94.8M | (674.8M) | 73.1M |
| Earnings from Discont. Ops | 11.4M | — | — | — | — |
| Bottom Line Net Income | (404.0M) | (70.8M) | 82.7M | (713.4M) | 63.4M |
| Per Share | |||||
| Basic EPS | ($3.08) | ($0.52) | $0.62 | ($5.32) | $0.52 |
| Diluted EPS | ($3.07) | ($0.52) | $0.61 | ($5.31) | $0.50 |
| Revenue Per Share | $23.11 | $24.01 | $24.38 | $23.85 | $22.14 |
| Shares | |||||
| Basic Shares Outstanding | 136.4M | 135.1M | 133.8M | 134.2M | 134.2M |
| Diluted Shares Outstanding | 136.4M | 135.1M | 135.5M | 134.4M | 139.0M |
| Profitability Metrics | |||||
| EBITDA | (13.8M) | 472.5M | 628.0M | (171.1M) | 558.5M |
| D&A | 333.6M | 381.9M | 365.3M | 420.6M | 351.2M |
| EBIT | (204.5M) | 90.6M | 262.7M | (591.7M) | 207.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026